Dupont Capital Management Corp Eagle Pharmaceuticals, Inc. Transaction History

Dupont Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$44.58 - $52.6 $179,211 - $211,452	-4,020 Reduced 26.01%	11,435 $566,000
Q4 2021 Jan 31, 2022	SELL	$45.82 - $56.9 $282,342 - $350,617	-6,162 Reduced 28.51%	15,455 $787,000
Q3 2021 Nov 03, 2021	SELL	$43.79 - $55.78 $133,822 - $170,463	-3,056 Reduced 12.39%	21,617 $1.21 Million
Q2 2021 Jul 30, 2021	BUY	$36.86 - $44.5 $909,446 - $1.1 Million	24,673 New	24,673 $1.06 Million
Q2 2019 Jul 30, 2019	SELL	$46.61 - $58.45 $845,085 - $1.06 Million	-18,131 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$36.72 - $67.73 $466,160 - $859,832	12,695 Added 233.54%	18,131 $730,000
Q1 2018 May 02, 2018	SELL	$52.16 - $66.86 $505,899 - $648,475	-9,699 Reduced 64.08%	5,436 $286,000
Q4 2017 Jan 31, 2018	BUY	$49.6 - $60.87 $750,696 - $921,267	15,135	15,135 $809,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.